Immunologist, studying DPhil Clinical Medicine at Oxford University.

Joined July 2011
Two new Science #Immunology studies provide insight into how different #COVID19 #vaccine types and dosing intervals affect T cell responses in humans. 📄: scim.ag/3JD7fgO 📄: scim.ag/3HLLDOQ
1
16
57
4,394
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines science.org/doi/10.1126/scii… @SciImmunology @PKlenermanLab @aliamini419 @TheLucyGarner @nprovine 🇬🇧
9
33
2,267
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines @SciImmunology @PKlenermanLab @nprovine 🇬🇧 science.org/doi/10.1126/scii…
7
1
30
1,915
Sam Murray retweeted
@SamMurray13 @UniofOxford explained why some people don't respond to #mRNA #vaccines
1
1
4
227
Sam Murray retweeted
Great talks from #yEFIS immunologists 👏 🍻 🎉 @pintofscienceIE
3
12
462
Last chance to get limited tickets for our Pint of Immunology event at JR Mahon’s tomorrow night!! @Irishimmunology @EFIS_Immunology
🎉Good news! Due to popular demand we got extra tickets! Secure your spot now, join us tomorrow Monday September 2 in Dublin city centre to listen to #yEFIS immunologists over a pint 👇 @pintofscienceIE
1
9
498
Sam Murray retweeted
🎉 Join us in Dublin City Centre to hear from four top immunology #yefis young scientists explain their research over a pint! Expect pints, craic, trivia and learning about cutting edge research. 🧬🔬 📍Register here: pintofscience.ie/event/pint-….
1
11
2
20
3,533
Introducing ‘Pint of Immunology’🍻 Join us Sept 2nd for a night of #immunology & pints for a European Congress of Immunology 2024 public outreach event! Open to all- get your free but limited tickets now pintofscience.ie/event/pint-… Please RT and share! @Irishimmunology @tcdTBSI
19
1
45
3,709
Join us and @Irishimmunology at #ECI2024 for a night of talks with #immunology researchers @SamMurray13 @Diiind @nanaborsa and John McGrath🦠 🕢 Monday, September 2nd at 7.30pm 📍 @jrmahons, Dublin 🎟️ FREE (and limited!) tickets are on our site now! 👉 tinyurl.com/2u86k8dd
1
17
3
37
5,842
📢Check our January issue ‼️ Featured article: ➡️A prospective, multicenter, three-cohort study evaluating contrast-induced #acutekidneyinjury (CI-AKI) in patients with #cirrhosis 🔗bit.ly/3HaNrgj Full issue👉bit.ly/36khmDF #LiverTwitter @EASLnews @EASLedu
19
57
5,210
🆕Article in press❕ Immune responses and clinical outcomes after COVID-19 vaccination in patients with #liverdisease and in #livertransplant recipients Read it here👉journal-of-hepatology.eu/art… @SamMurray13 @EleanorBarnesOx @tom_marjot #LiverTwitter
1
6
27
4,503
PITCH is proud to be a healthy control group for this very important and beautiful work on how liver patients across Europe respond to COVID vaccines
Delighted to see this out in @JHepatology Immune responses & clinical outcomes across 3 #COVID vaccine doses. Includes longitudinal assessment of T cells & Ab in #cirrhosis, LT, AIH, VLD & HC 🔗rb.gy/c0e17 Has been a privilege to work with such an amazing🌍 team👇
1
4
207
Sam Murray retweeted
What do we know about #covid in immunocompromised people? Katharine Lang looks at the continuing dangers of covid for immunocompromised people, the treatments available to them, and how antivirals such as remdesivir may help bmj.com/content/383/bmj.p161…
3
8
8
9,077
Now in @JHepatology from an international team (including @IHepatology members) - exploring immune responses and clinical outcomes after #COVID19 vaccination in patients with #liver disease and #OLT: doi.org/10.1016/j.jhep.2023.… @tom_marjot @EleanorBarnesOx @bhmullish @penny_manousou
7
19
1,585
Our paper was published TODAY in NATURE! The strongest genetic evidence for asymptomatic COVID-19. nature.com/articles/s41586-0… @jillahjillah @UNCCBiology @ChancellorGaber @GrasLab @hollenbachlab
13
53
11
179
62,779
Sam Murray retweeted
The magnificent Oxford University, UK. Read in this issue the outstanding #GUTRecentAdvances review by @tom_marjot et al on optimal timing of energy intake & the therapeutic potential of fasting in #NAFLD via bit.ly/3NS4HtH @OCDEM @OxfordBRC @OxfordMedSci @OUHospitals
7
1
12
7,330
New data from the OCTAVE trial shows #COVID19 vaccine responses in vulnerable patient groups for the first time. While infection rates were low in most at-risk patient groups, the risk of severe disease and death was higher in some groups. ⤵️ imperial.ac.uk/news/245933/s…
2
5
8
4,282
PCR assay for large-scale monitoring of the magnitude and duration of functional T cell immunity to SARS-CoV-2 nature.com/articles/s41587-0…
1
7
1,911